TrialObesity (Silver Spring, Md.)2020

Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults with Overweight or Obesity.

Harold E Bays et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.